|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4409 | |
| A61K 31/44 | |||
| A61K 45/06 | |||
| A61K 9/20 | |||
| A61K 9/48 | |||
| A01N 43/40 | |||
| A61P 25/00 |
| (11) | Patento numeris | 2464229 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10808713.1 |
| Europos patento paraiškos padavimo data | 2010-08-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-06-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-11-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/045211 |
| Data | 2010-08-11 |
| (87) | Numeris | WO 2011/019845 |
| Data | 2011-02-17 |
| (30) | Numeris | Data | Šalis |
| 233077 P | 2009-08-11 | US | |
| 233069 P | 2009-08-11 | US | |
| 239877 P | 2009-09-04 | US |
| (72) |
WESSEL, Thomas, C., US
BLIGHT, Andrew, US
|
| (73) |
Acorda Therapeutics, Inc.,
420 Saw Mill River Road, Ardsley, NY 10502,
US
|
| (54) | USE OF 4-AMINOPYRIDINE TO IMPROVE NEURO-COGNITIVE AND/OR NEURO-PSYCHIATRIC IMPAIRMENT IN PATIENTS WITH MULTIPLE SCLEROSIS |
| USE OF 4-AMINOPYRIDINE TO IMPROVE NEURO-COGNITIVE AND/OR NEURO-PSYCHIATRIC IMPAIRMENT IN PATIENTS WITH MULTIPLE SCLEROSIS |